The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

<div>(a) Forest plot displaying standardized mean difference and 95% confidence intervals for the impact of statin/ezetimibe combinational therapy vs statin monotherapy on oxidized LDL. (b) Leave-one-out sensitivity analyses for the impact of statin/ezetimibe combinational therapy vs statin monotherapy on circulating concentrations of oxidized LDL.</div>

Mediators of Inflammation

fig4

Figure 4

Figure 4: The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 

Figure 4 | The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 